|
COVER STORY
|
 High Expectations
Budget 2010
The forthcoming Budget 2010 is another opportunity for the finance minister Pranab Mukherjee to push the healthcare sector into a higher growth trajectory
|
|
|
BIOSPECIAL
|
2010, Year of Collaboration
2009 was a ‘Year of Consolidation’ for the life sciences industry. |
Bionomics of Biosimilars
Biosimilars are set to be the next big cash cow for India. However, players have many knots to untangle before they can have a firm grip over the economics of the market. |
India ready to battle swine flu
The battle against swine flu is getting intensified with the fruitful results of the clinical trials for developing H1N1 vaccines and diagnostics kits by pharmaceutical and diagnostic companies. |
H1N1 flu vaccine to hit the market soon
Increase in the number of swine flu cases, has put a lot of pressure on the government to look for an early vaccine trials and making it available in the market. |
Nanobio garments for wellness
New-Delhi based Advantage Organic Natural Technologies is exploring the concept of nanobio garments for the first time in India under the brand name Joy of Life and has obtained patent for the product. |
|
| BIOANALYSIS |
Why ain’t biotech IPOs happening in India?;
Companies use IPOs to raise money for expansion and growth. That was the story until the beginning of 2008 when globally, the markets were red hot. All that changed when the credit crunch set in, taking |
|
|
BIOBUSINESS |
Eisai expands India presence
Eisai, a pharma major from Japan, has given a thrust to their India operations by setting up a manufacturing and process research base in India |
|
|
| BIOEVENTS |
|
|
|
|
| BIORESEARCH |
"Purpose of BioSpin is to enter into new, emerging markets"
Harald Wolf, project manager of BioSpin for India |
 |
| BIOSUPPLIERS |
"India has vibrant biotech, pharmaceutical sectors"
- Carl-Johan Ivarsson, president, Qlucore |
 |
“We are seeing excellent growth in India, China”
- Dr Poonam Taneja, director, Global LCM Sales, and Asia and Latin America Distributor Sales, MDS Analytical Technologies |
 |
| BIOTALK |
"Indian biotech needs stringent regulations"
- Gunther Winkler, senior vice-president-International, Biogen Idec |
 |
|
|
|
|
